Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Centriacinar Emphysema

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Centriacinar Emphysema in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, NQ; Liu, CT; Oliaro, A; Tian, JH; Wang, DL1
Coupal, JJ; Lai, YL; Shih, WJ; Simmons, G1

Trials

1 trial(s) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Centriacinar Emphysema

ArticleYear
Prolonged lung retention of 131I-HIPDM in smokers.
    Panminerva medica, 1994, Volume: 36, Issue:3

    Topics: Adult; Chronic Disease; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Metabolic Clearance Rate; Middle Aged; Pulmonary Emphysema; Smoking; Time Factors

1994

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Centriacinar Emphysema

ArticleYear
[123I]HIPDM pulmonary imaging demonstrates elastase-induced pulmonary emphysema.
    Lung, 1993, Volume: 171, Issue:1

    Topics: Animals; Evaluation Studies as Topic; Iodine Radioisotopes; Iodobenzenes; Lung; Pancreatic Elastase; Pulmonary Emphysema; Radionuclide Imaging; Rats; Respiratory Function Tests; Technetium Tc 99m Aggregated Albumin

1993